Gilbert & Cook Inc. Sells 96 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gilbert & Cook Inc. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,068 shares of the medical equipment provider’s stock after selling 96 shares during the period. Gilbert & Cook Inc.’s holdings in Intuitive Surgical were worth $1,507,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. Creekmur Asset Management LLC lifted its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC bought a new position in Intuitive Surgical during the second quarter worth about $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the first quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.9 %

Shares of NASDAQ ISRG opened at $527.61 on Friday. The company’s fifty day moving average is $499.29 and its 200-day moving average is $457.89. The stock has a market cap of $187.92 billion, a price-to-earnings ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $295.02 and a twelve month high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 15.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 93.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ISRG. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.